Increase Efficiency in Experimentation with Design of Experiments
March 19, 2019 - Cytiva

QBDDesign of experiment will not only save you valuable tim

Biomanufacturing: The Cost of Unskilled Workers
March 18, 2019 - Cytiva talent

The Good and Bad of Biosimilars
March 18, 2019 - Cytiva

biosimilarsBiosimilars have been around for years, but the

Security of Supply
March 18, 2019 - Cytiva security of supply

Sensitive and Reproducible SPR-Based Concentration and Ligand-Bin


March 14, 2019 - Cytiva SPR-CQA

Analytical SEC: How Does Back Pressure Relate to Resolution?
March 14, 2019 - Cytiva

SECHigh resolution in HPLC is not achieved by applying back pressure to

Why, Why, Why…ELISA? A Look at the Benchmark HCP Assay
March 14, 2019 - Cytiva

Click here to read the article >>

Real-Time Characterization of Biotherapeutics and Comparability o


March 14, 2019 - BioPharm International

Real-Time Characterization of Biotherapeutics and Comparability of Biosimilars

Bispecific Antibody Purification: Insights and Case Studies
February 28, 2019 - Cytiva

New modalities, like bispecific antibodies, present unique challenges compared to mAb production. For purification, there’s not just one right answer to which

Make the Switch from ELISA to Biacore™ SPR-Based Assays Today
February 28, 2019 - Cytiva direct binding assay

Previous PageNext Page